Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.
Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.
Royal Free Hospital, London, UK. nkh174@hotmail.com.
Navjyot
N
Hansi
Nora
N
Thoua
Maresa
M
Carulli
Kuntal
K
Chakravarty
Simon
S
Lal
Anita
A
Smyth
Ariane
A
Herrick
Olagunju
O
Ogunbiyi
Jon
J
Shaffer
John
J
Mclaughlin
Christopher
C
Denton
Voon
V
Ong
Anton V
AV
Emmanuel
Charles D
CD
Murray
D015746:Abdominal Pain / Q000209:etiology / Q000628:therapy; D032921:Consensus; D003248:Constipation / Q000209:etiology / Q000628:therapy; D003967:Diarrhea / Q000209:etiology / Q000628:therapy; D015154:Esophageal Motility Disorders / Q000209:etiology / Q000628:therapy; D005242:Fecal Incontinence / Q000209:etiology / Q000628:therapy; D005764:Gastroesophageal Reflux / Q000209:etiology / Q000628:therapy; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000628:therapy*; D006801:Humans; D044342:Malnutrition / Q000209:etiology / Q000628:therapy; D017410:Practice Guidelines as Topic; D012595:Scleroderma, Systemic / Q000150:complications / Q000628:therapy*; D006113:United Kingdom